对稳定素-2的多种新型血凝固剂血配体的鉴定
Mary Underwood1, Felipe Da Veiga Leprevost2, Venkatesha Basrur2
1Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA.
Journal of thrombosis and haemostasis : JTH
|February 19, 2025
概括
在STAB2 (stabilin-2) 的遗传变异增加了凝血风险. 这项研究确定了由稳定素-2 清除的关键蛋白质配体,揭示了与稳定素-2 缺乏相关的静脉血栓栓塞的潜在机制.
科学领域:
- 蛋白质组学是指蛋白质组学.
- 分子生物学分子生物学
- 血管生物学 血管生物学
背景情况:
- 在STAB2基因中有害的变异与静脉血栓栓塞的风险增加有关.
- STAB2对稳定素-2进行编码,该受体对清除蛋白质至关重要,主要存在于肝脏和脏中.
- 稳定素-2 缺乏可能会导致前血栓性状态,原因是前血栓性蛋白质的清除受损,尽管这些配体仍然未被识别.
研究的目的:
- 用近距离生物化蛋白学来识别稳定素-2的血配体.
- 为了研究稳定素-2在血液静止蛋白清除中的作用.
主要方法:
- 接近生物化蛋白质组学 (使用稳定素-2-TurboID) 来标记和识别血配体.
- 质谱测量用于识别生物化蛋白质.
- 流细胞计和共聚焦显微镜以评估连接体结合和细胞局部化.
- 在Stab2-缺乏的小鼠中分析连接体血水平.
主要成果:
- 确定了28种特定的稳定素-2连接体.
- 证实了·维勒布兰德因子,纤维素,前列血,肝素辅因子II,高分子量基因素,等离子素和C4b结合蛋白的相互作用.
- 肝素辅因子II,高分子量基因因子,等离子体和纤维素因子显著结合稳定素-2.
- 所有已识别的配体以稳定素-2依赖的方式与溶酶体结合.
- 在Stab2缺乏的小鼠中,连结体水平没有显著增加,这表明稳定素-2不是小鼠的主要清除受体.
结论:
- 近距离标记蛋白质组学是有效的识别受体连接体.
- 稳定素-2 改变血静性蛋白质的清除可能会导致与破坏性 STAB2 变体相关的静脉血栓栓塞风险增加.
相关概念视频
Cytoskeletal Linker Proteins - Plakins
2.2K
Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
2.2K
Clot Retraction and Fibrinolysis
3.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
597
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
597
Intracellular Signaling Affects Focal Adhesions
2.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.5K


